Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 3, 2001, Pages 251-256

  Colle, Isabelle ^a   Moreau, Richard ^a   Pessione, Fabienne ^b   Rassiat, Emmanuel ^a   Heller, Jörg ^a   Chagneau, Carine ^a   Pateron, Dominique ^a   Barrière, Eric ^a   Condat, Bertrand ^a   Sogni, Philippe ^a   Valla, Dominique ^a   Lebrec, Didier ^a  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

Cirrhosis; Portal hypertension; Renal haemodynamics; Systemic haemodynamics

Indexed keywords

ADULT; ARTICLE; ASCITES; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMIC MONITORING; HUMAN; KIDNEY BLOOD FLOW; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; VENOUS PRESSURE;

ALDOSTERONE; ASCITES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENIN;

EID: 0035093165     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200103000-00006     Document Type: Article

References (21)

1. Arroyo V, Ginès P. Mechanism of sodium retention and ascites formation in cirrhosis. J Hepatol 1993; 17 (suppl 2): S24-S28.
2. Rector WG. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver 1986; 6: 221-226.
3. Morali GA, Sniderman KW, Deitel KM, Tobe S, Witt-Sullivan H, Simon M. et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol 1992; 16: 249-250.
4. Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jimenez W. et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28: 416-422.
5. Moreau R, Gaudin C, Hadengue A, Braillon A, Roulot D, Bacq Y. et al. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure. Nephron 1993; 65: 359-363.
6. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodès J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157.
7. Poynard T, Degott C, Munoz C, Lebrec D. Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis.: Effect of acute alcoholic hepatitis on portal hypertension. Dig Dis Sci 1987; 32: 337-343.
8. Roulot D, Moreau R, Gaudin C, Bacq Y, Braillon A, Hadengue A. et al. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. Gastroenterology 1992; 102: 1309-1318.
9. Brenard R, Moreau R, Pussard E, Champigneulle B, Gaudin C, Hadengue A. et al. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in cirrhotic patients. J Hepatol 1992; 14: 347-356.
10. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T. et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996; 25: 135-144.
11. Gadano A, Moreau R, Vachiery F, Soupison T, Yang S, Cailmail S. et al. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. J Hepatol 1997; 26: 1229-1234.
12. Moreau R, Chagneau C, Heller J, Chevenne D, Langlet P, Deltenre P, et al. Haemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose. Scand J Gastroenterol 2000; in press.
13. Ginès P, Arroyo V, Vargas B, Planas R, Casafont F, Panés J. et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325: 829-835.
14. Valla D, Bercoff E, Menu Y, Bataille C, Lebrec D. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis. Gastroenterology 1984; 86: 1400-1403.
15. Moreau R, Soubrane O, Sogni P, Hadengue A, Gaudin C, Lin HC. et al. Hemodynamic and neurohumoral responses to amino acid infusion in patients with cirrhosis. Gastroenterology 1992; 103: 601-608.
16. Moreau R, Lee SS, Soupison T, Roche-Sicot J, Sicot C. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol 1988; 7: 98-105.
17. Moreau R, Hadengue A, Soupison T, Mamzer MF, Kirstetter P, Saraux JL. et al. Arterial and mixed venous acid-base status in patients with cirrhosis.: Influence of liver failure. Liver 1993; 13: 20-24.
18. Bernardi M, Di Marco C, Trevisani F, De Collibus C, Fornalé L, Baraldini M. et al. The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change. Hepatology 1992; 16: 341-346.
19. Gadano A, Moreau R, Heller J, Chagneau C, Vachiéry F, Trombino C. et al. Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis. Gut 1999; 45: 117-121.
20. Ginés P, Arroyo V, Rodès J. Pharmacotherapy of ascites associated with cirrhosis. Drugs 1992; 43: 316-332.
21. Bernardi M, Trevisani F, Gasbarrini A, Gasbarrini G. Hepatorenal disorders: role of the renin-angiotensin-aldosterone system. Semin Liver Dis 1994; 14: 23-34.